Clinical Trial Update: Hyperphenylalaninemia in Cerebral Malaria

View source ↗

Summary

A University of Utah–sponsored study investigating hyperphenylalaninemia in cerebral malaria (associated with Plasmodium falciparum malaria) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Malaria
• Malaria

Snippet

Sponsor: University of Utah | Conditions: Plasmodium Falciparum Malaria | Status: COMPLETED